NCT01524679 Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen Status COMPLETED Phase PHASE2
NCT01491295 Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Status UNKNOWN Phase PHASE4
NCT01487876 Efficacy and Safety of Dual-plasmid Hepatitis B Virus DNA Vaccine in Chronic Hepatitis B Patients Status UNKNOWN Phase PHASE2
NCT01471535 HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated Status COMPLETED Phase NA
NCT01464281 A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml Status UNKNOWN Phase NA
NCT01436539 Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients Status UNKNOWN Phase PHASE4
NCT01412567 Vaccine+HBIG Versus Vaccine+Placebo for Newborns of HBsAg+ Mothers Status COMPLETED Phase NA
NCT01401400 Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study Status COMPLETED Phase N/A
NCT01380951 Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB) Status UNKNOWN Phase PHASE4
NCT01379508 Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept Status COMPLETED Phase PHASE4
NCT01373684 PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients Status COMPLETED Phase PHASE4
NCT01360892 Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography Status UNKNOWN Phase N/A
NCT01360879 Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease Status UNKNOWN Phase N/A
NCT01342185 Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B Status UNKNOWN Phase PHASE3
NCT01337791 Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels Status COMPLETED Phase PHASE4
NCT01326546 Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients Status COMPLETED Phase PHASE2
NCT01320943 Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB Status COMPLETED Phase PHASE4
NCT01277601 Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B Status COMPLETED Phase PHASE4